Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Otolaryngologic Clinics of North AmericaAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Bidirectional association between asthma and chronic rhinosinusitis: Two longitudinal follow-up studies using a national sample cohort.Sci Rep. 2020; 10: 1-10
- Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe.Allergy. 2012; 67: 91-98
- Comorbidities are associated with different features of severe asthma.Clin Mol Allergy. 2018; 16https://doi.org/10.1186/S12948-018-0103-X
- Comparative clinical and airway inflammatory features of asthmatics with or without polyps.Rhinology. 2010; 48: 420-425
- The relation of airway obstruction to asthma, chronic rhinosinusitis and age: results from a population survey of adults.Allergy. 2014; 69: 1205
- Differentiation of chronic sinus diseases by measurement of inflammatory mediators.Allergy. 2006; 61: 1280-1289
- Endotypes of chronic rhinosinusitis with nasal polyps: pathology and possible therapeutic implications.J Allergy Clin Immunol Pract. 2020; 8: 1514-1519
- Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease.J Allergy Clin Immunol. 2008; 122: 961-968
- Th17 response and its regulation in inflammatory upper airway diseases.Clin Exp Allergy. 2015; 45: 602-612
- Chronic rhinosinusitis: the rationale for current treatments.Expert Rev Clin Immunol. 2017; 13: 259-270
- Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis.J Allergy Clin Immunol Pract. 2019; 7: 2812-2820.e3
- Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers.J Allergy Clin Immunol. 2016; 137: 1449-1456.e4
- Type 2 inflammation in chronic rhinosinusitis without nasal polyps: Another relevant endotype.J Allergy Clin Immunol. 2020; 146: 337-343.e6
Fokkens W.J., Lund V.J., Hopkins C., et al., European Position Paper on Rhinosinusitis and Nasal Polyps 2020, Rhinology, 58 (Suppl S29), 2020, 1-464.
- Precision medicine in chronic rhinosinusitis with nasal polyps.Curr Allergy Asthma Rep. 2018; 18https://doi.org/10.1007/S11882-018-0776-8
- Chronic rhinosinusitis with nasal polyps.N Engl J Med. 2019; 381: 55-63
- Saline irrigation for chronic rhinosinusitis.Cochrane Database Syst Rev. 2016; 2016https://doi.org/10.1002/14651858.CD011995.pub2
- Different types of intranasal steroids for chronic rhinosinusitis.Cochrane Database Syst Rev. 2016; 2016https://doi.org/10.1002/14651858.CD011993.pub2
- Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.Cochrane Database Syst Rev. 2016; 2016https://doi.org/10.1002/14651858.CD011996.pub2
- Utilization patterns of topical intranasal steroid therapy for chronic rhinosinusitis: a canadian population-based analysis.JAMA Otolaryngol Head Neck Surg. 2016; 142: 1056-1062
- Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma.J Allergy Clin Immunol. 2015; 135: 701-709.e5
- Use of off-label nasal steroid irrigations in long-term management of chronic rhinosinusitis.Ear Nose Throat J. 2021; 100: 329-334
- Corticosteroid nasal irrigations are more effective than simple sprays in a randomized double-blinded placebo-controlled trial for chronic rhinosinusitis after sinus surgery.Int Forum Allergy Rhinol. 2018; 8: 461-470
- Topical steroids for nasal polyps.Cochrane Database Syst Rev. 2012; 12: CD006549
- Effect of budesonide added to large-volume, low-pressure saline sinus irrigation for chronic rhinosinusitis: a randomized clinical trial.JAMA Otolaryngol Head Neck Surg. 2018; 144: 605
- The possibility of short-term hypothalamic-pituitary-adrenal axis suppression with high-volume, high-dose nasal mometasone irrigation in postsurgical patients with chronic rhinosinusitis.Int Forum Allergy Rhinol. 2022; 12: 249-256
- Safety of long-term high-volume sinonasal budesonide irrigations for chronic rhinosinusitis.Int Forum Allergy Rhinol. 2016; 6: 228-232
- NAVIGATE I: randomized, placebo-controlled, double-blind trial of the exhalation delivery system with fluticasone for chronic rhinosinusitis with nasal polyps.Am J Rhinol Allergy. 2019; 33: 69-82
- NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis.J Allergy Clin Immunol. 2019; 143: 126-134.e5
- Efficacy of steroid eluting stents in management of chronic rhinosinusitis following endoscopic sinus surgery: updated meta-analysis.Int Forum Allergy Rhinol. 2019; 9: 1443
- A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps.Int Forum Allergy Rhinol. 2018; 8: 471-481
- RESOLVE: bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis after sinus surgery: 6-month outcomes from a randomized, controlled, blinded study.Int Forum Allergy Rhinol. 2016; 6: 573-581
- RESOLVE: a randomized, controlled, blinded study of bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis.Int Forum Allergy Rhinol. 2014; 4: 861-870
- Topical therapies for management of chronic rhinosinusitis: steroid implants.Int Forum Allergy Rhinol. 2019; 9: S22-S26
- Phase 1 clinical study to assess the safety of a novel drug delivery system providing long-term topical steroid therapy for chronic rhinosinusitis.Int Forum Allergy Rhinol. 2019; 9: 378-387
- Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy.J Allergy Clin Immunol. 2012; 129: 1522-1528.e5
- Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis.Cochrane Database Syst Rev. 2016; 2016https://doi.org/10.1002/14651858.CD011992.pub2
- Oral corticosteroid exposure and adverse effects in asthmatic patients.J Allergy Clin Immunol. 2018; 141: 110-116.e7
- Effects of inhaled corticosteroid and short courses of oral corticosteroids on bone mineral density in asthmatic patients : a 4-year longitudinal study.Chest. 2001; 120: 1468-1473
- Risk of infectious complications in patients taking glucocorticosteroids.Rev Infect Dis. 1989; 11: 954-963
- Should oral corticosteroids be used in medical therapy for chronic rhinosinusitis? A risk analysis.Laryngoscope. 2021; 131: 473-481
- Efficacy of targeted medical therapy in chronic rhinosinusitis, and predictors of failure.Am J Rhinol Allergy. 2009; 23: 396-400
- The fate of chronic rhinosinusitis sufferers after maximal medical therapy.Int Forum Allergy Rhinol. 2014; 4: 525-532
- Prevalence and abundance of Staphylococcus aureus in the middle meatus of patients with chronic rhinosinusitis, nasal polyps, and asthma.Int Forum Allergy Rhinol. 2013; 3: 267-271
- Staphylococcus aureus nasal colonization and asthma in adults: systematic review and meta-analysis.J Allergy Clin Immunol Pract. 2019; 7: 606-615.e9
- Prospective open-label evaluation of long-term low-dose doxycycline for difficult-to-treat chronic rhinosinusitis with nasal polyps.Rhinology. 2017; 55: 175-180
- Oral steroids and doxycycline: two different approaches to treat nasal polyps.J Allergy Clin Immunol. 2010; 125https://doi.org/10.1016/J.JACI.2010.02.020
- Efficacy of long-term low-dose macrolide therapy in preventing early recurrence of nasal polyps after endoscopic sinus surgery.Int Forum Allergy Rhinol. 2014; 4: 533-541
- A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis.Laryngoscope. 2006; 116: 189-193
- Workstream 2: The MACRO Programme | Workstream 2: The MACRO Programme.(Available at:) (Accessed May 8, 2022)
- Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial.Lancet Respir Med. 2022; 10: 337-346
- Chronic rhinosinusitis with nasal polyps and asthma.J Allergy Clin Immunol Pract. 2021; 9: 1133-1141
- Nucala | european medicines agency.(Available at:) (Accessed May 1, 2022)
- Dupixent | european medicines agency.(Available at:) (Accessed May 1, 2022)
- Xolair | european medicines agency.(Available at:) (Accessed May 1, 2022)
- Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps.Int Forum Allergy Rhinol. 2021; 11: 1087-1101
- Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: a real-world study.Int Forum Allergy Rhinol. 2021; 11: 1152-1161
- Biologics for chronic rhinosinusitis.Cochrane Database Syst Rev. 2021; 2021https://doi.org/10.1002/14651858.CD013513.PUB3
- Dupilumab improved health-related quality of life in asthma patients with comorbid chronic rhinosinusitis: QUEST study.Am Thorac Soc Int. 2022; : A4845https://doi.org/10.1164/AJRCCM-CONFERENCE.2022.205.1_MEETINGABSTRACTS.A4845
- Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease.J Allergy Clin Immunol. 2022; https://doi.org/10.1016/j.jaci.2022.04.007
- Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps.Allergy. 2022; 77: 670-674
- Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet Respir Med. 2021; 9: 1141-1153https://doi.org/10.1016/S2213-2600(21)00097-7
- Effects of reslizumab on asthma outcomes in a subgroup of eosinophilic asthma patients with self-reported chronic rhinosinusitis with nasal polyps.J Allergy Clin Immunol Pract. 2019; 7: 589-596.e3
- Efficacy of reslizumab with asthma, chronic sinusitis with nasal polyps and elevated blood eosinophils.J Allergy Clin Immunol. 2016; 137: AB86
- Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial.J Allergy Clin Immunol. 2022; 149: 1309-1317.e12
- Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.J Allergy Clin Immunol. 2020; 146: 595-605
- EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management.J Allergy Clin Immunol. 2021; 147: 29-36
- Which is the best biologic for nasal polyps: dupilumab, omalizumab, or mepolizumab? A network meta-analysis.Int Arch Allergy Immunol. 2022; 183: 279-288
- Mepolizumab decreases tissue eosinophils while increasing type-2 cytokines in eosinophilic chronic rhinosinusitis.Clin Exp Allergy. 2022; https://doi.org/10.1111/cea.14152
- Biologicals and endoscopic sinus surgery for severe uncontrolled chronic rhinosinusitis with nasal polyps: an economic perspective.J Allergy Clin Immunol Pract. 2022; https://doi.org/10.1016/j.jaip.2022.02.017
- Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.Lancet (London, England). 2019; 394: 1638-1650
- Cost utility analysis of dupilumab versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps.Laryngoscope. 2021; 131: E26-E33
- Cost-effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease.Int Forum Allergy Rhinol. 2021; 11: 1626-1636
Article info
Publication history
Published online: October 17, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
